Abstract
The study of epigenetic regulation of genes involved in breast cancer provides a level of complexity that lends understanding to the factors contributing to this prevalent disease. Recent evidence from studies that employ pharmacological agents such as trichostatin A and/or 5-aza-cytidine to alter epigenetic changes have been shown to reactivate key regulators such as p21 in breast cancer cells or explain silencing mechanisms of p16 that could lead to carcinogenesis. The roles of telomerase and Bmi-1 expression in the cellular processes of senescence, aging, and the maintenance of stem cells are discussed in relation to breast carcinogenesis, the implications of breast cancer stem cells, and the feasibility of these genes as epigenetic targets in cancer therapy.
Keywords: epigenetics, breast cancer, hdis, demethylating agents, metastasis, telomerase, Bmi, stem cells
Current Genomics
Title: The Epigenetics of Breast Carcinogenesis and Metastasis
Volume: 6 Issue: 3
Author(s): S. M.O. Phipps, W. K. Woodfin and T. O. Tollefsbol
Affiliation:
Keywords: epigenetics, breast cancer, hdis, demethylating agents, metastasis, telomerase, Bmi, stem cells
Abstract: The study of epigenetic regulation of genes involved in breast cancer provides a level of complexity that lends understanding to the factors contributing to this prevalent disease. Recent evidence from studies that employ pharmacological agents such as trichostatin A and/or 5-aza-cytidine to alter epigenetic changes have been shown to reactivate key regulators such as p21 in breast cancer cells or explain silencing mechanisms of p16 that could lead to carcinogenesis. The roles of telomerase and Bmi-1 expression in the cellular processes of senescence, aging, and the maintenance of stem cells are discussed in relation to breast carcinogenesis, the implications of breast cancer stem cells, and the feasibility of these genes as epigenetic targets in cancer therapy.
Export Options
About this article
Cite this article as:
Phipps M.O. S., Woodfin K. W. and Tollefsbol O. T., The Epigenetics of Breast Carcinogenesis and Metastasis, Current Genomics 2005; 6 (3) . https://dx.doi.org/10.2174/1389202053971956
DOI https://dx.doi.org/10.2174/1389202053971956 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Is Fibroblast Growth Factor Receptor 4 a Suitable Target of Cancer Therapy?
Current Pharmaceutical Design Recent Advances in the Development of Immunoadhesins for Immune Therapy and as Anti-Infective Agents
Recent Patents on Anti-Infective Drug Discovery Monoclonal Antibodies as Cancer Therapeutics
Recent Patents on Biotechnology The Antiprogestogen Mifepristone: A Review
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Review of Procedures Used for the Extraction of Anti-Cancer Compounds from Tropical Plants
Anti-Cancer Agents in Medicinal Chemistry Peptide Agonists and Antagonists with Potential Application in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Immune Modulation by Plasmid DNA-mediated Cytokine Gene Transfer
Current Pharmaceutical Design Overview of the Formulations and Analogs in the Taxanes' Story
Current Medicinal Chemistry Repurposing of Benzimidazole Scaffolds for HER2 Positive Breast Cancer Therapy: An <i>In-Silico</i> Approach
Current Drug Research Reviews 19F: A Versatile Reporter for Non-Invasive Physiology and Pharmacology Using Magnetic Resonance
Current Medicinal Chemistry Mining the Genome for Susceptibility to Complex Neurological Disorders
Current Molecular Medicine Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Fibrinolytic Protease from Marine Streptomyces rubiginosus VITPSS1
Cardiovascular & Hematological Agents in Medicinal Chemistry Importance and Limitations of Chemotherapy Among the Available Treatments for Gastrointestinal Tumours
Anti-Cancer Agents in Medicinal Chemistry The Development of MetAP-2 Inhibitors in Cancer Treatment
Current Medicinal Chemistry Bioengineered 3D Scaffolds in Cancer Research: Focus on Epithelial to Mesenchymal Transition and Drug Screening
Current Pharmaceutical Design Pharmacological Control of Autophagy: Therapeutic Perspectives in Inflammatory Bowel Disease and Colorectal Cancer
Current Pharmaceutical Design MicroRNAs in Cancer: Small Molecules, Big Chances
Anti-Cancer Agents in Medicinal Chemistry The Role of microRNA-126 in Vascular Homeostasis
Current Vascular Pharmacology Quercetin as a Systemic Chemopreventative Agent: Structural and Functional Mechanisms
Mini-Reviews in Medicinal Chemistry